Ajoy Roy, MD
Gastroenterology · Oswego, NYNPI 1487633400
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 25.2% of the total.
Across 158 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$788
- Pfizer$567
- Gilead$436
- Johnson & Johnson$300
- Takeda Pharmaceuticals U.S.A., Inc.$294
- Phathom Pharmaceuticals, Inc.$155
- plus $585 from 15 others
What the payments were for
- Consulting fees$191%
- Food & beverage$2,93794%
- Education$1685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $788 |
| Pfizer | 47 | $567 |
| Gilead | 9 | $436 |
| Johnson & Johnson(2 entities) | 11 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $294 |
| Phathom Pharmaceuticals, Inc. | 3 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $109 |
| Intercept Pharmaceuticals, Inc. | 4 | $58 |
| Bristol Myers Squibb | 3 | $45 |
| Ferring Pharmaceuticals Inc. | 3 | $44 |
| Braintree Laboratories, Inc. | 2 | $38 |
| Sanofi | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| QOL Medical, LLC | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,124 in reported general payments places this provider in the 60th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Oswego
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.